Clinical Trial Detail

NCT ID NCT04199026
Title Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

sarcoma

Therapies

Irinotecan

Doxorubicin

Ifosfamide

Temozolomide

Temsirolimus

Ganitumab

Pazopanib

Everolimus

Vincristine Sulfate

Age Groups: adult child senior

No variant requirements are available.